A modified protocol for mechanical extraction of stromal‑vascular fraction in combination with platelet‑rich plasma for osteochondral defects of the knee joint

Introduction Mechanical isolation of the stromal vascular fraction (SVF) from autologous adipose tissue represents a promising approach in regenerative treatment of osteochondral defects of the knee joint. However, intra-articular SVF administration may be associated with a post-injection synovial reaction, which decreases the tolerability of the procedure and complicates early clinical assessment. Therefore, optimization of the cell preparation protocol aimed at improving biological purity and reducing reactive intra-articular changes remains clinically relevant.

Purpose To evaluate the impact of a modified mechanical SVF isolation protocol combined with highly concentrated platelet-rich plasma (P-PRP) on the severity and duration of post-injection synovial reaction in patients with osteochondral knee defects.

Materials and Methods A retrospective-and-prospective comparative non-randomized study included 62 patients. Group I consisted of 41 patients treated using the standard mechanical SVF protocol. Group II included 21 patients treated with a modified protocol incorporating liposaspirate washing, mechanical emulsification through a 0.6 mm filter, and P-PRP preparation using double centrifugation with ACD-A anticoagulant. Comparative analysis was performed based on the severity and duration of post-injection synovial reaction using clinical and instrumental stratification and ultrasound assessment.

Results In the standard protocol group, mild synovial reaction was observed in 4 (9.8 %) patients, moderate in 16 (39.0 %), and severe in 21 (51.2 %). In the modified protocol group, mild reaction was recorded in 11 (52.4 %) patients, moderate in 7 (33.3 %), and severe in 3 (14.3 %). The median duration of synovial reaction was 11 (9–12) days in the standard protocol and 5 (3–7) days in the modified protocol (p < 0.001).

Discussion The addition of liposaspirate washing and mechanical purification through a 0.6 mm filter in the protocol, along with double centrifugation using ACD-A, reduced the final injection volume and increased platelet concentration in PRP (> 1 × 10⁶/µL), which was associated with decreased severity and shorter duration of synovial reaction.

Conclusion The modified mechanical SVF isolation protocol improves early post-injection tolerability by reducing the severity and duration of post-injection synovial reaction. The proposed technique is reproducible and may represent a promising approach for optimizing regenerative therapy in patients with osteochondral knee defects.

1. Crossley KM, Stefanik JJ, Selfe J, et al. 2016 Patellofemoral pain consensus statement from the 4th International Patellofemoral Pain Research Retreat, Manchester. Part 1: Terminology, definitions, clinical examination, natural history, patellofemoral osteoarthritis and patient-reported outcome measures. Br J Sports Med. 2016;50(14):839-843. doi: 10.1136/bjsports-2016-096384.

2. Zheng W, Li H, Hu K, et al. Chondromalacia patellae: current options and emerging cell therapies. Stem Cell Res Ther. 2021;12(1):412. doi: 10.1186/s13287-021-02478-4.

3. Dursun M, Ozsahın M, Altun G. Prevalence of chondromalacia patella according to patella type and patellofemoral geometry: a retrospective study. Sao Paulo Med J. 2022;140(6):755-761. doi: 10.1590/1516-3180.2021.0206.R2.10012022.

4. Özdemir M, Kavak RP. Chondromalacia Patella among Military Recruits with Anterior Knee Pain: Prevalence and Association with Patellofemoral Malalignment. Indian J Orthop. 2019;53(6):682-688. doi: 10.4103/ortho.IJOrtho_655_18.

5. Smith BE, Selfe J, Thacker D, et al. Incidence and prevalence of patellofemoral pain: A systematic review and metaanalysis. PLoS One. 2018;13(1):e0190892. doi: 10.1371/journal.pone.0190892.

6. Crossley KM, Callaghan MJ, van Linschoten R. Patellofemoral pain. Br J Sports Med. 2016;50(4):247-250. doi: 10.1136/bjsports-2015-h3939rep.

7. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745-1759. doi: 10.1016/S0140-6736(19)304179.

8. Sellam J, Courties A, Eymard F, et al. Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis. Joint Bone Spine. 2020;87(6):548-555. doi: 10.1016/j.jbspin.2020.09.004.

9. Hunter DJ, March L, Chew M. Osteoarthritis in 2020 and beyond: a Lancet Commission. Lancet. 2020;396(10264):1711-1712. doi: 10.1016/S0140-6736(20)32230-3.

10. V S, R A, Haran H, et al. Enhanced Bone Marrow Aspirate Concentrate (BMAC) Preparation Strategy in the Management of Chondromalacia Patella: A Case Report. Cureus. 2024;16(4):e59321. doi: 10.7759/cureus.59321.

11. Filardo G, Kon E, Roffi A, et al. Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration. Knee Surg Sports Traumatol Arthrosc. 2015;23(9):2459-2474. doi: 10.1007/s00167-013-2743-1.

12. Tretyakov AA, Zinovkin DA, Karpenko FN, et al. Pathomorphologic evaluation of intra-articular injections of soluble platelet-rich plasma for treatment of experimental osteoarthritis. Genij Ortopedii. 2024;30(1):90-98. doi: 10.18019/1028-4427-2024-30-1-90-98.

13. Popkov AV, Popkov DA, Kobyzev AE, et al. Positive experience of full-layer filling of articular cartilage defect using a degradable implant with a bioactive surface in combination with platelet-rich blood plasma (experimental study). Genij Ortopedii. 2020;26(3):392-397. doi: 10.18019/1028-4427-2020-26-3-392-397.

14. Malanin DA, Demkin SA, Demeshchenko MV, Baidova KV. Platelet-rich autologous plasma for the treatment of patients with grade II osteoarthritis of the knee. Genij Ortopedii. 2017;23(1):44-51. doi: 10.18019/1028-4427-2017-23-1-44-51,

15. Tonnard P, Verpaele A, Peeters G, et al. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013;132(4):1017-1026. doi: 10.1097/PRS.0b013e31829fe1b0.

16. Krupina EA, Fajzrahmanov RR, Pavlovskij OA, et al. Molecular and Biological аspects of Platelet-Rich Plasma Therapies. Bulletin of Pirogov National Medical & Surgical Center. 2020;15(3-2):80-85. (In Russ.) doi: 10.25881/BPNMSC.2020.30.34.015.

17. Yasyukevich AS, Zagorodny GM, Gulevich NP, Puchko AA. The impact of the anticoagulant type on the homogeneity of autologous platelet-enriched plasma obtained by two-stage centrifugation from a small amounts of blood for therapeutic purposes. Applied Sports Science. 2020;2(12):109-118. (In Russ.)

18. Stevens HP, van Boxtel J, van Dijck R, van Dongen JA. Platelet Rich STROMA, the Combination of PRP and tSVF and Its Potential Effect on Osteoarthritis of the Knee. Applied Sciences. 2020;10(14):4691. doi: 10.3390/app10144691.

19. Goncharov EN, Koval OA, Bezuglov EN, et al. Stromal Vascular Fraction Therapy for Knee Osteoarthritis: A Systematic Review. Medicina (Kaunas). 2023;59(12):2090. doi: 10.3390/medicina59122090.

20. Bora P, Majumdar AS. Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation. Stem Cell Res Ther. 2017;8(1):145. doi: 10.1186/s13287-017-0598-y.

21. Russo A, Condello V, Madonna V, et al. Autologous and micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis. J Exp Orthop. 2017;4(1):33. doi: 10.1186/s40634-017-0108-2.

22. Totlis T, Emfietzis PK, Niti A, et al. A modified technique for mechanical isolation of stromal vascular fraction yields increased final product volume and high viable nucleated cells count. J Exp Orthop. 2025;12(3):e70378. doi: 10.1002/jeo2.70378.

23. Maeda T, Sobajima S, Matsumoto T, et al. Comparison of short-term clinical outcomes of intra-articular injection of micro-fragmented adipose tissue and stromal vascular fraction cells for knee osteoarthritis treatment: A retrospective single-center cohort study. Regen Ther. 2025;29:91-99. doi: 10.1016/j.reth.2025.02.013.

24. Smyshlyaev IA, Gilfanov SI, Kopylov VA, et al. Safety and effectiveness of intraarticular administration of adiposederived stromal vascular fraction for treatment of knee articular cartilage degenerative damage: preliminary results of a clinical trial. Traumatology and Orthopedics of Russia. 2017;23(3):17-31. doi: 10.21823/2311-2905-2017-23-3-17-31.